Physician profile
Chelsi Jackson
NPI 1811281504
$358.30
in general payments reported to CMS, 2019-2025
12 companies · $29.95 in 2025
The $29.95 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $80.20 · 2021: $107 · 2022: $109 · 2023: $31.97 · 2025: $29.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $63.61 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $54.43 | 2019-2021 | |
| Irhythm Technologies, INC. | $45.09 | 2021-2023 | Zio Xt Patch |
| Pfizer INC. | $43.33 | 2019 | |
| Lilly USA, LLC | $31.45 | 2022 | |
| Sanofi-Aventis U.S. LLC | $29.95 | 2025 | |
| Almatica Pharma LLC | $21.19 | 2021 | |
| Nevro Corp. | $15.92 | 2022 | |
| Amarin Pharma, INC. | $14.49 | 2021 | |
| Exact Sciences Corporation | $13.67 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $12.95 | 2022 | |
| Xeris Pharmaceuticals, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chelsi Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.